Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:administered_by |
oral tablet
|
| gptkbp:casnumber |
1421370-80-0
|
| gptkbp:chemical_formula |
C22 H24 N4 O2 S
|
| gptkbp:developed_by |
gptkb:Blueprint_Medicines
|
| https://www.w3.org/2000/01/rdf-schema#label |
BLU-285
|
| gptkbp:is_tested_for |
Phase 1/2 trials
|
| gptkbp:mechanism_of_action |
inhibitor of tyrosine kinase
|
| gptkbp:status |
clinical trials
|
| gptkbp:targets |
mutant forms of PDGFRA
|
| gptkbp:used_for |
treatment of gastrointestinal stromal tumors (GISTs)
|
| gptkbp:bfsParent |
gptkb:Blueprint_Medicines
|
| gptkbp:bfsLayer |
4
|